Bas van Rhijn

1.7k total citations
20 papers, 798 citations indexed

About

Bas van Rhijn is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bas van Rhijn has authored 20 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 5 papers in Urology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bas van Rhijn's work include Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (10 papers) and Urological Disorders and Treatments (5 papers). Bas van Rhijn is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (10 papers) and Urological Disorders and Treatments (5 papers). Bas van Rhijn collaborates with scholars based in Netherlands, Canada and United States. Bas van Rhijn's co-authors include Theodorus van der Kwast, C.C. Abbou, Marie‐Aude Lefrère‐Belda, François Radvanyi, Dominique Chopin, Jacky Bonaventure, Sixtina Gil Diez de Medina, C Billerey, Élie Serge Zafrani and Jean Paul Thiery and has published in prestigious journals such as American Journal Of Pathology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

Bas van Rhijn

20 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bas van Rhijn Netherlands	11	571	361	155	144	103	20	798
Riley E. Alexander United States	14	269 0.5×	142 0.4×	180 1.2×	168 1.2×	90 0.9×	19	573
Donatella Tirindelli Danesi Italy	12	252 0.4×	140 0.4×	131 0.8×	158 1.1×	50 0.5×	24	495
C. Stoffregen Germany	15	181 0.3×	201 0.6×	246 1.6×	264 1.8×	43 0.4×	41	678
Stephanie A. Mullane United States	12	520 0.9×	156 0.4×	182 1.2×	431 3.0×	53 0.5×	43	785
U. Studer Switzerland	11	122 0.2×	146 0.4×	168 1.1×	112 0.8×	134 1.3×	16	530
Arndt Hartmann Germany	8	238 0.4×	183 0.5×	137 0.9×	130 0.9×	28 0.3×	13	575
William Crabtree United States	13	373 0.7×	224 0.6×	142 0.9×	188 1.3×	73 0.7×	29	753
Marie‐Aude Lefrère‐Belda France	10	423 0.7×	387 1.1×	126 0.8×	139 1.0×	38 0.4×	12	817
Yoichiro Kato Japan	13	163 0.3×	133 0.4×	168 1.1×	187 1.3×	42 0.4×	54	449
Trishna Goswami United States	10	305 0.5×	122 0.3×	176 1.1×	472 3.3×	20 0.2×	41	737

Countries citing papers authored by Bas van Rhijn

Since Specialization

Citations

This map shows the geographic impact of Bas van Rhijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas van Rhijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas van Rhijn more than expected).

Fields of papers citing papers by Bas van Rhijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas van Rhijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas van Rhijn. The network helps show where Bas van Rhijn may publish in the future.

Co-authorship network of co-authors of Bas van Rhijn

This figure shows the co-authorship network connecting the top 25 collaborators of Bas van Rhijn. A scholar is included among the top collaborators of Bas van Rhijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bas van Rhijn. Bas van Rhijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wondergem, Maurits, Thierry N. Boellaard, Kurdo Barwari, et al.. (2023). The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?. Journal of Clinical Medicine. 12(10). 3367–3367. 3 indexed citations

Sylvester, Richard, et al.. (2020). Risk tables for predicting progression using the 1973 and 2004/2016 WHO grading classification systems in primary Ta/T1 non-muscle invasive urothelial carcinoma of the bladder: A multicenter EAU NMIBC guidelines panel study. European Urology Open Science. 19. e1789–e1789. 1 indexed citations

Jubber, Ibrahim, Shahrokh F. Shariat, Samantha Conroy, et al.. (2019). Non-visible haematuria for the Detection of Bladder, Upper Tract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis. European Urology. 77(5). 583–598. 34 indexed citations

Meijer, Richard P., Floris J. Pos, Martijn Kerst, et al.. (2018). Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome. Urologic Oncology Seminars and Original Investigations. 36(6). 307.e1–307.e8. 8 indexed citations

Dijk, Nick van, Pia Kvistborg, Ton N. Schumacher, et al.. (2018). Neo-adjuvant ipilimumab and nivolumab in high risk resectable bladder urothelial cancer (NABUCCO). Annals of Oncology. 29. viii329–viii329. 1 indexed citations

Gild, Philipp, M. Vetterlein, Paolo Gontero, et al.. (2018). The impact of cigarette smoking on adverse pathological features and survival in patients undergoing radical cystectomy for urinary bladder cancer - a prospective, European multicenter study of the EAU young academic urologists urothelial carcinoma group. European Urology Supplements. 17(2). e1031–e1032. 3 indexed citations

Voskuilen, Charlotte S., Roland Seiler, Michael Rink, et al.. (2018). Urothelial carcinoma in bladder diverticula: A multicenter analysis of characteristics and treatment outcome in 110 patients. European Urology Supplements. 17(2). e532–e533. 1 indexed citations

Boström, Peter J., Tuomas Mirtti, Bas van Rhijn, et al.. (2016). Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy. Bladder Cancer. 2(2). 263–272. 6 indexed citations

Grivas, Nikolaos, Esther Wit, Floris J. Pos, et al.. (2016). Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression. International Journal of Radiation Oncology*Biology*Physics. 97(2). 347–354. 15 indexed citations

10.

Kamat, Ashish M., Antonia Vlahou, John A. Taylor, et al.. (2014). Considerations on the use of urine markers in the management of patients with high-grade non–muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 32(7). 1069–1077. 27 indexed citations

11.

Schmitz‐Dräger, Bernd J., Tilman Todenhöfer, Bas van Rhijn, et al.. (2014). Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non–muscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 32(7). 1061–1068. 27 indexed citations

12.

Babjuk, M., M. Bürger, Richard Zigeuner, et al.. (2013). Guidelines on Non-muscle invasive Bladder Cancer. 19 indexed citations

13.

Türker, Polat, Peter J. Boström, Marcelo Langer Wroclawski, et al.. (2012). Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome. British Journal of Urology. 110(6). 804–811. 86 indexed citations

14.

Skeldon, Sean, Kara Semotiuk, Melyssa Aronson, et al.. (2012). Patients with Lynch Syndrome Mismatch Repair Gene Mutations Are at Higher Risk for Not Only Upper Tract Urothelial Cancer but Also Bladder Cancer. European Urology. 63(2). 379–385. 76 indexed citations

15.

Boström, Peter J., Sultan Alkhateeb, Greg Trottier, et al.. (2011). Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer. British Journal of Urology. 109(1). 70–76. 23 indexed citations

16.

Mir, Maria Carmen, Enrique Trilla, Inés M. de Torres, et al.. (2010). Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome. British Journal of Urology. 108(2b). E71–6. 31 indexed citations

17.

Zlotta, Alexandre R., Greg Trottier, Bas van Rhijn, et al.. (2010). 690 NERVE-SPARING RADICAL PROSTATECTOMY IN SELECTED HIGH-RISK AND LOCALLY ADVANCED PROSTATE CANCERS IS ASSOCIATED WITH LOW POSITIVE MARGIN RATES USING A COMBINATION OF PREOPERATIVE MRI, SPECIAL INSTRUMENTATION AND INTRA-OPERATIVE FROZEN SECTIONS. European Urology Supplements. 9(2). 226–226. 1 indexed citations

18.

Rhijn, Bas van. (2005). Molecular Diagnosis and Prognosis of Bladder Cancer : towards the implementation of molecular markers in clinical practice. 1 indexed citations

19.

Gaast, Ate van der, et al.. (2002). A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy. Cancer Chemotherapy and Pharmacology. 49(4). 342–345. 61 indexed citations

20.

Billerey, C, Dominique Chopin, Marie‐Hélène Aubriot‐Lorton, et al.. (2001). Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors. American Journal Of Pathology. 158(6). 1955–1959. 374 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact